These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30221545)

  • 1. How promising is neuroactive steroid drug discovery?
    Carta MG; Paribello P; Preti A
    Expert Opin Drug Discov; 2018 Nov; 13(11):993-995. PubMed ID: 30221545
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential clinical uses of neuroactive steroids.
    Zorumski CF; Mennerick S; Isenberg KE; Covey DF
    Curr Opin Investig Drugs; 2000 Nov; 1(3):360-9. PubMed ID: 11249720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redirecting the revolution: new developments in drug development for psychiatry.
    Brady LS; Potter WZ; Gordon JA
    Expert Opin Drug Discov; 2019 Dec; 14(12):1213-1219. PubMed ID: 31545131
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptor variants and the development of centrally acting medications
.
    Neale SA; Kambara K; Salt TE; Bertrand D
    Dialogues Clin Neurosci; 2019; 21(2):149-157. PubMed ID: 31636489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol-like discriminative stimulus effects of endogenous neuroactive steroids: effect of ethanol training dose and dosing procedure.
    Bowen CA; Purdy RH; Grant KA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):405-11. PubMed ID: 10087031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics.
    Marx CE; Stevens RD; Shampine LJ; Uzunova V; Trost WT; Butterfield MI; Massing MW; Hamer RM; Morrow AL; Lieberman JA
    Neuropsychopharmacology; 2006 Jun; 31(6):1249-63. PubMed ID: 16319920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthroughs in neuroactive steroid drug discovery.
    Blanco MJ; La D; Coughlin Q; Newman CA; Griffin AM; Harrison BL; Salituro FG
    Bioorg Med Chem Lett; 2018 Jan; 28(2):61-70. PubMed ID: 29223589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing and sustaining India's capacity for preclinical drug discovery.
    Lewis DI; Patel BK; Kumar BD; Medhi B
    Indian J Pharmacol; 2018; 50(5):225-226. PubMed ID: 30636824
    [No Abstract]   [Full Text] [Related]  

  • 9. Ophthalmic Drug Discovery and Development.
    Gukasyan HJ; Hailu S; Karami TK
    Pharm Res; 2019 Mar; 36(5):69. PubMed ID: 30887132
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurosteroids and potential therapeutics: Focus on pregnenolone.
    Vallée M
    J Steroid Biochem Mol Biol; 2016 Jun; 160():78-87. PubMed ID: 26433186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial drug discovery: lessons of history and future strategies.
    Travis A; Chernova O; Chernov V; Aminov R
    Expert Opin Drug Discov; 2018 Nov; 13(11):983-985. PubMed ID: 30136874
    [No Abstract]   [Full Text] [Related]  

  • 12. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside.
    Strous RD; Maayan R; Weizman A
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):155-69. PubMed ID: 16257183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurosteroids and neuroactive drugs in mental disorders.
    Pisu MG; Serra M
    Life Sci; 2004 May; 74(26):3181-97. PubMed ID: 15094320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric Modulation of Muscarinic Receptors by Cholesterol, Neurosteroids and Neuroactive Steroids.
    Szczurowska E; Szánti-Pintér E; Randáková A; Jakubík J; Kudova E
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we seeing a resurgence in the use of natural products for new drug discovery?
    Li F; Wang Y; Li D; Chen Y; Dou QP
    Expert Opin Drug Discov; 2019 May; 14(5):417-420. PubMed ID: 30810395
    [No Abstract]   [Full Text] [Related]  

  • 16. The preclinical discovery and development of cariprazine for the treatment of schizophrenia.
    Wesołowska A; Partyka A; Jastrzębska-Więsek M; Kołaczkowski M
    Expert Opin Drug Discov; 2018 Aug; 13(8):779-790. PubMed ID: 29722587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Have nanomedicines progressed as much as we'd hoped for in drug discovery and development?
    Sarmento B
    Expert Opin Drug Discov; 2019 Aug; 14(8):723-725. PubMed ID: 31161834
    [No Abstract]   [Full Text] [Related]  

  • 18. Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery.
    Saikin SK; Kreisbeck C; Sheberla D; Becker JS; A AG
    Expert Opin Drug Discov; 2019 Jan; 14(1):1-4. PubMed ID: 30488727
    [No Abstract]   [Full Text] [Related]  

  • 19. Advancement of Technology for Drug Discovery and Development - Part II.
    Niu B
    Curr Top Med Chem; 2020; 20(1):3. PubMed ID: 31994458
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in Drug Discovery and Development in Geriatric Psychiatry.
    C Conley A; A Newhouse P
    Curr Psychiatry Rep; 2018 Mar; 20(2):10. PubMed ID: 29504046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.